Article(id=1329869412947046908, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.01.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1669564800000, receivedDateStr=2022-11-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995175825, onlineDateStr=2026-11-18, pubDate=1673280000000, pubDateStr=2023-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995175825, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995175825, creator=13701087609, updateTime=1794995175825, updator=13701087609, issue=Issue{id=1329869401546928487, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='1', pageStart='1', pageEnd='100', issueExtLink='null', onlineDate='null', pubDate='1673280000000', pubDateStr='2023-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995173107, creator='13701087609', updateTime=1794995764620, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329871882981060993, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329871882981060994, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=27, endPage=31, ext={EN=ArticleExt(id=1329869413119013373, articleId=1329869412947046908, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on dipeptidyl peptidase-4 inhibitors in the treatment of diabetic nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Diabetic nephropathy (DN) is one of the most common complications in patients with diabetes mellitus (DM), which is mainly treated by medication in clinic. Oral hypoglycemic agents can not only optimize blood glucose control and reduce the risk of hypoglycemia, but also affect the progression of DN. Among them, dipeptidyl peptidase-4 inhibitor (DPP-4i) is an oral hypoglycemic agent that plays a role in changes in the level of the incretin system. DPP-4i showed additional pleiotropic effects in vitro models, including reduced inflammation, fibrosis and oxidative damage, further indicating a potential renal protective effect. DPP-4i may help delay DN progression, but further studies are needed to prove their specific benefit to the kidney. This article reviewed the biological function of DPP-4i, the mechanism on DN, and the clinical efficacy, in order to provide new ideas for clinical treatment.

, authors=Jun TAO1, 2, Dongsheng CHENG1, Niansong WANG1, *, authorsList=Jun TAO, Dongsheng CHENG, Niansong WANG, authorCompany=null, correspAuthors=Niansong WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869413324534270, articleId=1329869412947046908, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=二肽基肽酶-4抑制剂治疗糖尿病肾病研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetes mellitus,DM)最常见的并发症之一,目前临床上以药物治疗为主。口服降糖药物除可优化血糖控制、降低低血糖发生风险外,还可影响DN进展。其中,二肽基肽酶-4抑制剂(dipeptidyl peptidase-4 inhibitor,DPP-4i)是一种在肠促胰岛素系统水平变化中起作用的口服降糖药物。DPP-4i在体外模型中显示出额外的多效性作用,包括减少炎症、纤维化和氧化损伤等,进一步表明其具有潜在的肾脏保护作用。DPP-4i可能有助于延缓DN进展,但尚需进一步研究证明其对肾脏的特异性益处。现就DPP-4i的生物学功能、对DN的作用机制以及临床疗效等进行综述,以期为临床治疗提供新思路。

, authors=陶钧1, 2, 程东生1, 汪年松1, *, authorsList=陶钧, 程东生, 汪年松, authorCompany=null, correspAuthors=汪年松, authorNote=

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

, correspAuthorsNote=
汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=gDY9zTq4gylJqYgPXNHSDQ==, magXml=pWhRoOhQKQFWkptP/I/jig==, pdfUrl=null, pdf=sNZW+AOctU1GVBhE1/5fwQ==, pdfFileSize=1518347, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=nLDb5FDxUat9GglQ6di+Fw==, mapNumber=null, fund=null)}, authors=[Author(id=1329869413681050118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869413769130505, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413681050118, language=EN, stringName=Jun TAO, firstName=Jun, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869413848822282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413681050118, language=CN, stringName=陶钧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
2.上海交通大学附属上海市第六人民医院老年病科,上海 200233, bio={"content":"

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

"}, bioImg=null, bioContent=

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)]), AuthorCompany(id=1329869413588775426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=2., ext=[AuthorCompanyExt(id=1329869413597164035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413609746948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属上海市第六人民医院老年病科,上海 200233)])]), Author(id=1329869413915931148, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869414024983054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413915931148, language=EN, stringName=Dongsheng CHENG, firstName=Dongsheng, middleName=null, lastName=CHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869414113063439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413915931148, language=CN, stringName=程东生, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869414188560913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869414264058387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869414188560913, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869414335361556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869414188560913, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])])], keywords=[Keyword(id=1329869414436024853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=EN, orderNo=1, keyword=dipeptidyl peptidase-4 inhibitor), Keyword(id=1329869414503133718, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=EN, orderNo=2, keyword=diabetic nephropathy), Keyword(id=1329869414561853975, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=EN, orderNo=3, keyword=mechanism of action), Keyword(id=1329869414641545752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=EN, orderNo=4, keyword=renal protection), Keyword(id=1329869414700266009, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=CN, orderNo=1, keyword=二肽基肽酶-4抑制剂), Keyword(id=1329869414763180570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=CN, orderNo=2, keyword=糖尿病肾病), Keyword(id=1329869414830289435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=CN, orderNo=3, keyword=作用机制), Keyword(id=1329869414889009692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, language=CN, orderNo=4, keyword=肾脏保护)], refs=[Reference(id=1329869415161639455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Forst T, Mathieu C, Giorgino F, et al. New strategies to improve clinical outcomes for diabetic kidney disease[J]. Bio Med Central Med, 2022, 20(1): 337., articleTitle=null, refAbstract=null), Reference(id=1329869415245525536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Mohsen M, Elberry AA, Mohamed Rabea A, et al. Recent therapeutic targets in diabetic nephropathy[J]. Int J Clin Pract, 2021, 75(11): e14650., articleTitle=null, refAbstract=null), Reference(id=1329869415325217313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Qiu DD, Liu J, Shi JS, et al. Renoprotection provided by dipeptidyl peptidase-4 inhibitors in combination with angiotensin receptor blockers in patients with type 2 diabetic nephropathy[J]. Chin Med J (Engl), 2018, 131(22): 2658-2665., articleTitle=null, refAbstract=null), Reference(id=1329869415396520482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Daza-Arnedo R, Rico-Fontalvo JE, Pájaro-Galvis N, et al. Dipeptidyl peptidase-4 inhibitors and diabetic kidney disease: a narrative review[J]. Kidney Med, 2021, 3(6): 1065-1073., articleTitle=null, refAbstract=null), Reference(id=1329869415472017955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Nishimura R, Takeshima T, Iwasaki K, et al. Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis[J]. Br Med J Open, 2022, 12(3): e045966., articleTitle=null, refAbstract=null), Reference(id=1329869415534932516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2020, 16(11): 642-653., articleTitle=null, refAbstract=null), Reference(id=1329869415589458469, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Stoian AP, Sachinidis A, Stoica RA, et al. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes[J]. Metabolism, 2020, 109: 154295., articleTitle=null, refAbstract=null), Reference(id=1329869415656567334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Lambeir AM, Durinx C, Scharpé S, et al. Dipeptidyl-peptidase Ⅳ from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP Ⅳ[J]. Crit Rev Clin Lab Sci, 2003, 40(3): 209-294., articleTitle=null, refAbstract=null), Reference(id=1329869415727870503, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Gallwitz B. Clinical use of DPP-4 inhibitors[J]. Front Endocrinol (Lausanne), 2019, 10: 389., articleTitle=null, refAbstract=null), Reference(id=1329869415807562280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Nistala R, Habibi J, Lastra G, et al. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition[J]. Endocrinology, 2014, 155(6): 2266-2276., articleTitle=null, refAbstract=null), Reference(id=1329869415899836969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhong J, Rao X, Rajagopalan S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease[J]. Atherosclerosis, 2013, 226(2): 305-314., articleTitle=null, refAbstract=null), Reference(id=1329869415966945834, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Thomas MC. The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes[J]. Diabetes Metab, 2017, 43(Suppl 1): 2S20-2S27., articleTitle=null, refAbstract=null), Reference(id=1329869416067609131, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Klemann C, Wagner L, Stephan M, et al. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system[J]. Clin Exp Immunol, 2016, 185(1): 1-21., articleTitle=null, refAbstract=null), Reference(id=1329869416151495212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang Z, Grigo C, Steinbeck J, et al. Soluble DPP4 originates in part from bone marrow cells and not from the kidney[J]. Peptides, 2014, 57: 109-117., articleTitle=null, refAbstract=null), Reference(id=1329869416222798381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Tiruppathi C, Miyamoto Y, Ganapathy V, et al. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase Ⅳ-positive and dipeptidyl peptidase Ⅳ-negative rat strains[J]. J Biol Chem, 1990, 265(3): 1476-1483., articleTitle=null, refAbstract=null), Reference(id=1329869416323461678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Girardi AC, Fukuda LE, Rossoni LV, et al. Dipeptidyl peptidase Ⅳ inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule[J]. Am J Physiol Renal Physiol, 2008, 294(2): F414- F422., articleTitle=null, refAbstract=null), Reference(id=1329869416390570543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang J, Campitelli J, Hu G, et al. Increase in DPP-Ⅳ in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin[J]. Life Sci, 2007, 81(4): 272-279., articleTitle=null, refAbstract=null), Reference(id=1329869416457679408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Glorie LL, Verhulst A, Matheeussen V, et al. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury[J]. Am J Physiol Renal Physiol, 2012, 303(5): F681-F688., articleTitle=null, refAbstract=null), Reference(id=1329869416524788273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Reichetzeder C, von Websky K, Tsuprykov O, et al. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury[J]. Br J Pharmacol, 2017, 174(14): 2273-2286., articleTitle=null, refAbstract=null), Reference(id=1329869416604480050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen YT, Wallace CG, Yang CC, et al. DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning[J]. Oncotarget, 2017, 8(33): 54821-54837., articleTitle=null, refAbstract=null), Reference(id=1329869416684171827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Hasan AA, Hocher B. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy[J]. J Mol Endocrinol, 2017, 59(1): R1-R10., articleTitle=null, refAbstract=null), Reference(id=1329869416747086388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=von Websky K, Reichetzeder C, Hocher B. Physiology and pathophysiology of incretins in the kidney[J]. Curr Opin Nephrol Hypertens, 2014, 23(1): 54-60., articleTitle=null, refAbstract=null), Reference(id=1329869416818389557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Skov J. Effects of GLP-1 in the kidney[J]. Rev Endocr Metab Disord, 2014, 15(3): 197-207., articleTitle=null, refAbstract=null), Reference(id=1329869416898081334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Mima A, Hiraoka-Yamomoto J, Li Q, et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes[J]. Diabetes, 2012, 61(11): 2967-2979., articleTitle=null, refAbstract=null), Reference(id=1329869416956801591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Mikov M, Pavlović N, Stanimirov B, et al. DPP-4 inhibitors: renoprotective potential and pharmacokinetics in type 2 diabetes mellitus patients with renal impairment[J]. Eur J Drug Metab Pharmacokinet, 2020, 45(1): 1-14., articleTitle=null, refAbstract=null), Reference(id=1329869417011327544, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Nicotera R, Casarella A, Longhitano E, et al. Antiproteinuric effect of DPP-Ⅳ inhibitors in diabetic and non-diabetic kidney diseases[J]. Pharmacol Res, 2020, 159: 105019., articleTitle=null, refAbstract=null), Reference(id=1329869417103602233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Jo CH, Kim S, Park JS, et al. Anti-inflammatory action of sitagliptin and linagliptin in doxorubicin nephropathy[J]. Kidney Blood Press Res, 2018, 43(3): 987-999., articleTitle=null, refAbstract=null), Reference(id=1329869417183294010, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Gangadharan Komala M, Gross S, Zaky A, et al. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes[J]. Nephrology (Carlton), 2016, 21(5): 423-431., articleTitle=null, refAbstract=null), Reference(id=1329869417267180091, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Matsui T, Nakashima S, Nishino Y, et al. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis[J]. Lab Invest, 2015, 95(5): 525-533., articleTitle=null, refAbstract=null), Reference(id=1329869417623695932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Surendran S, Sapkal R, Paul D, et al. Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: an in vitro and in vivo approach[J]. Chem Biol Interact, 2020, 315: 108909., articleTitle=null, refAbstract=null), Reference(id=1329869417699193405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Kodera R, Shikata K, Takatsuka T, et al. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes[J]. Biochem Biophys Res Commun, 2014, 443(3): 828-833., articleTitle=null, refAbstract=null), Reference(id=1329869417787273790, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Xie Y, Bowe B, Gibson AK, et al. Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases[J]. Diabetes Care, 2020, 43(11): 2859-2869., articleTitle=null, refAbstract=null), Reference(id=1329869417934074431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Han SJ, Ha KH, Lee N, et al. Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a nationwide population-based study[J]. Diabetes Obes Metab, 2021, 23(3): 682-691., articleTitle=null, refAbstract=null), Reference(id=1329869418005377600, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Cooper ME, Perkovic V, Groop PH, et al. Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria[J]. J Hypertens, 2019, 37(6): 1294-1300., articleTitle=null, refAbstract=null), Reference(id=1329869418072486465, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Cristiano EA, Miles JM, Worsham S, et al. Decreased mortality after long-term treatment with dipeptidyl peptidase-4 inhibitors: a retrospective study of U. S. veterans with type 2 diabetes[J]. Endocr Pract, 2022, 28(1): 8-15., articleTitle=null, refAbstract=null), Reference(id=1329869418131206722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Mosenzon O, Leibowitz G, Bhatt DL, et al. Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 trial[J]. Diabetes Care, 2017, 40(1): 69-76., articleTitle=null, refAbstract=null), Reference(id=1329869418194121283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Rosenstock J, Perkovic V, Johansen OE, et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial[J]. J Am Med Assoc, 2019, 321(1): 69-79., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329869414989672989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, awardId=81770741; 81870504; 82270761, language=CN, fundingSource=国家自然基金面上项目(81770741; 81870504; 82270761), fundOrder=null, country=null), Fund(id=1329869415069364766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, awardId=null, language=CN, fundingSource=上海市领军人才(058)资助, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)]), AuthorCompany(id=1329869413588775426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=2., ext=[AuthorCompanyExt(id=1329869413597164035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413609746948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属上海市第六人民医院老年病科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.01.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.01.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.01.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.01.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1673280000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
二肽基肽酶-4抑制剂治疗糖尿病肾病研究进展
陶钧 1, 2 , 程东生 1 , 汪年松 1, *
世界临床药物 | 医药专论 2023,44(1): 27-31
收起
收藏切换
世界临床药物 |医药专论 2023 , 44 (1) : 27 -31
二肽基肽酶-4抑制剂治疗糖尿病肾病研究进展
全屏
[Author(id=1329869413681050118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869413769130505, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413681050118, language=EN, stringName=Jun TAO, firstName=Jun, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869413848822282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413681050118, language=CN, stringName=陶钧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
2.上海交通大学附属上海市第六人民医院老年病科,上海 200233, bio={"content":"

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

"}, bioImg=null, bioContent=

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)]), AuthorCompany(id=1329869413588775426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=2., ext=[AuthorCompanyExt(id=1329869413597164035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413609746948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413588775426, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属上海市第六人民医院老年病科,上海 200233)])]), Author(id=1329869413915931148, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869414024983054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413915931148, language=EN, stringName=Dongsheng CHENG, firstName=Dongsheng, middleName=null, lastName=CHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869414113063439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869413915931148, language=CN, stringName=程东生, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869414188560913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869414264058387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869414188560913, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869414335361556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, authorId=1329869414188560913, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869413492306431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, xref=1., ext=[AuthorCompanyExt(id=1329869413509083648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869413521666561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869412947046908, companyId=1329869413492306431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])])]
陶钧1, 2, 程东生1, 汪年松1, *
作者信息
  • 1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
  • 2.上海交通大学附属上海市第六人民医院老年病科,上海 200233
通讯作者:
汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
作者简介:

陶钧,主治医师,博士研究生,研究方向:慢性肾脏病营养治疗、慢性肾脏病肌少症的发病机制及防治。

Research progress on dipeptidyl peptidase-4 inhibitors in the treatment of diabetic nephropathy
Jun TAO1, 2, Dongsheng CHENG1, Niansong WANG1, *
Affiliations
  • 1.Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
  • 2.Department of Geriatrics, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
出版时间: 2023-01-10 doi: 10.13683/j.wph.2023.01.005
文章导航
收藏切换

糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetes mellitus,DM)最常见的并发症之一,目前临床上以药物治疗为主。口服降糖药物除可优化血糖控制、降低低血糖发生风险外,还可影响DN进展。其中,二肽基肽酶-4抑制剂(dipeptidyl peptidase-4 inhibitor,DPP-4i)是一种在肠促胰岛素系统水平变化中起作用的口服降糖药物。DPP-4i在体外模型中显示出额外的多效性作用,包括减少炎症、纤维化和氧化损伤等,进一步表明其具有潜在的肾脏保护作用。DPP-4i可能有助于延缓DN进展,但尚需进一步研究证明其对肾脏的特异性益处。现就DPP-4i的生物学功能、对DN的作用机制以及临床疗效等进行综述,以期为临床治疗提供新思路。

二肽基肽酶-4抑制剂  /  糖尿病肾病  /  作用机制  /  肾脏保护

Diabetic nephropathy (DN) is one of the most common complications in patients with diabetes mellitus (DM), which is mainly treated by medication in clinic. Oral hypoglycemic agents can not only optimize blood glucose control and reduce the risk of hypoglycemia, but also affect the progression of DN. Among them, dipeptidyl peptidase-4 inhibitor (DPP-4i) is an oral hypoglycemic agent that plays a role in changes in the level of the incretin system. DPP-4i showed additional pleiotropic effects in vitro models, including reduced inflammation, fibrosis and oxidative damage, further indicating a potential renal protective effect. DPP-4i may help delay DN progression, but further studies are needed to prove their specific benefit to the kidney. This article reviewed the biological function of DPP-4i, the mechanism on DN, and the clinical efficacy, in order to provide new ideas for clinical treatment.

dipeptidyl peptidase-4 inhibitor  /  diabetic nephropathy  /  mechanism of action  /  renal protection
陶钧, 程东生, 汪年松. 二肽基肽酶-4抑制剂治疗糖尿病肾病研究进展. 世界临床药物, 2023 , 44 (1) : 27 -31 . DOI: 10.13683/j.wph.2023.01.005
Jun TAO, Dongsheng CHENG, Niansong WANG. Research progress on dipeptidyl peptidase-4 inhibitors in the treatment of diabetic nephropathy[J]. World Clinical Drug, 2023 , 44 (1) : 27 -31 . DOI: 10.13683/j.wph.2023.01.005
  • 国家自然基金面上项目(81770741; 81870504; 82270761)
  • 上海市领军人才(058)资助
参考文献 引证文献
排序方式:
[1]
Forst T, Mathieu C, Giorgino F, et al. New strategies to improve clinical outcomes for diabetic kidney disease[J]. Bio Med Central Med, 2022, 20(1): 337.
[2]
Mohsen M, Elberry AA, Mohamed Rabea A, et al. Recent therapeutic targets in diabetic nephropathy[J]. Int J Clin Pract, 2021, 75(11): e14650.
[3]
Qiu DD, Liu J, Shi JS, et al. Renoprotection provided by dipeptidyl peptidase-4 inhibitors in combination with angiotensin receptor blockers in patients with type 2 diabetic nephropathy[J]. Chin Med J (Engl), 2018, 131(22): 2658-2665.
[4]
Daza-Arnedo R, Rico-Fontalvo JE, Pájaro-Galvis N, et al. Dipeptidyl peptidase-4 inhibitors and diabetic kidney disease: a narrative review[J]. Kidney Med, 2021, 3(6): 1065-1073.
[5]
Nishimura R, Takeshima T, Iwasaki K, et al. Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis[J]. Br Med J Open, 2022, 12(3): e045966.
[6]
Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2020, 16(11): 642-653.
[7]
Stoian AP, Sachinidis A, Stoica RA, et al. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes[J]. Metabolism, 2020, 109: 154295.
[8]
Lambeir AM, Durinx C, Scharpé S, et al. Dipeptidyl-peptidase Ⅳ from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP Ⅳ[J]. Crit Rev Clin Lab Sci, 2003, 40(3): 209-294.
[9]
Gallwitz B. Clinical use of DPP-4 inhibitors[J]. Front Endocrinol (Lausanne), 2019, 10: 389.
[10]
Nistala R, Habibi J, Lastra G, et al. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition[J]. Endocrinology, 2014, 155(6): 2266-2276.
[11]
Zhong J, Rao X, Rajagopalan S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease[J]. Atherosclerosis, 2013, 226(2): 305-314.
[12]
Thomas MC. The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes[J]. Diabetes Metab, 2017, 43(Suppl 1): 2S20-2S27.
[13]
Klemann C, Wagner L, Stephan M, et al. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system[J]. Clin Exp Immunol, 2016, 185(1): 1-21.
[14]
Wang Z, Grigo C, Steinbeck J, et al. Soluble DPP4 originates in part from bone marrow cells and not from the kidney[J]. Peptides, 2014, 57: 109-117.
[15]
Tiruppathi C, Miyamoto Y, Ganapathy V, et al. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase Ⅳ-positive and dipeptidyl peptidase Ⅳ-negative rat strains[J]. J Biol Chem, 1990, 265(3): 1476-1483.
[16]
Girardi AC, Fukuda LE, Rossoni LV, et al. Dipeptidyl peptidase Ⅳ inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule[J]. Am J Physiol Renal Physiol, 2008, 294(2): F414- F422.
[17]
Yang J, Campitelli J, Hu G, et al. Increase in DPP-Ⅳ in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin[J]. Life Sci, 2007, 81(4): 272-279.
[18]
Glorie LL, Verhulst A, Matheeussen V, et al. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury[J]. Am J Physiol Renal Physiol, 2012, 303(5): F681-F688.
[19]
Reichetzeder C, von Websky K, Tsuprykov O, et al. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury[J]. Br J Pharmacol, 2017, 174(14): 2273-2286.
[20]
Chen YT, Wallace CG, Yang CC, et al. DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning[J]. Oncotarget, 2017, 8(33): 54821-54837.
[21]
Hasan AA, Hocher B. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy[J]. J Mol Endocrinol, 2017, 59(1): R1-R10.
[22]
von Websky K, Reichetzeder C, Hocher B. Physiology and pathophysiology of incretins in the kidney[J]. Curr Opin Nephrol Hypertens, 2014, 23(1): 54-60.
[23]
Skov J. Effects of GLP-1 in the kidney[J]. Rev Endocr Metab Disord, 2014, 15(3): 197-207.
[24]
Mima A, Hiraoka-Yamomoto J, Li Q, et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes[J]. Diabetes, 2012, 61(11): 2967-2979.
[25]
Mikov M, Pavlović N, Stanimirov B, et al. DPP-4 inhibitors: renoprotective potential and pharmacokinetics in type 2 diabetes mellitus patients with renal impairment[J]. Eur J Drug Metab Pharmacokinet, 2020, 45(1): 1-14.
[26]
Nicotera R, Casarella A, Longhitano E, et al. Antiproteinuric effect of DPP-Ⅳ inhibitors in diabetic and non-diabetic kidney diseases[J]. Pharmacol Res, 2020, 159: 105019.
[27]
Jo CH, Kim S, Park JS, et al. Anti-inflammatory action of sitagliptin and linagliptin in doxorubicin nephropathy[J]. Kidney Blood Press Res, 2018, 43(3): 987-999.
[28]
Gangadharan Komala M, Gross S, Zaky A, et al. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes[J]. Nephrology (Carlton), 2016, 21(5): 423-431.
[29]
Matsui T, Nakashima S, Nishino Y, et al. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis[J]. Lab Invest, 2015, 95(5): 525-533.
[30]
Surendran S, Sapkal R, Paul D, et al. Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: an in vitro and in vivo approach[J]. Chem Biol Interact, 2020, 315: 108909.
[31]
Kodera R, Shikata K, Takatsuka T, et al. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes[J]. Biochem Biophys Res Commun, 2014, 443(3): 828-833.
[32]
Xie Y, Bowe B, Gibson AK, et al. Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases[J]. Diabetes Care, 2020, 43(11): 2859-2869.
[33]
Han SJ, Ha KH, Lee N, et al. Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a nationwide population-based study[J]. Diabetes Obes Metab, 2021, 23(3): 682-691.
[34]
Cooper ME, Perkovic V, Groop PH, et al. Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria[J]. J Hypertens, 2019, 37(6): 1294-1300.
[35]
Cristiano EA, Miles JM, Worsham S, et al. Decreased mortality after long-term treatment with dipeptidyl peptidase-4 inhibitors: a retrospective study of U. S. veterans with type 2 diabetes[J]. Endocr Pract, 2022, 28(1): 8-15.
[36]
Mosenzon O, Leibowitz G, Bhatt DL, et al. Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 trial[J]. Diabetes Care, 2017, 40(1): 69-76.
[37]
Rosenstock J, Perkovic V, Johansen OE, et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial[J]. J Am Med Assoc, 2019, 321(1): 69-79.
2023年第44卷第1期
13
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.01.005
  • 接收时间:2022-11-28
  • 首发时间:2026-11-18
  • 出版时间:2023-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-11-28
基金
国家自然基金面上项目(81770741; 81870504; 82270761)
上海市领军人才(058)资助
作者信息
    1.上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
    2.上海交通大学附属上海市第六人民医院老年病科,上海 200233

通讯作者:

汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.01.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏